PROCEPT BioRobotics — Third Quarter 2026 Earnings Summary

PROCEPT BioRobotics reported third-quarter 2026 total revenue of $98.3 million, representing an 18% increase compared to the same period in 2025. The company delivered 62 U.S. HYDROS systems during the quarter and achieved over 13,400 U.S. procedures, a 22% year-over-year growth. Gross margin for the quarter was 66%, while the company recorded a net loss of $26.5 million and an adjusted EBITDA loss of $9.8 million. PROCEPT reaffirmed its full-year 2026 financial guidance, projecting revenue between $390 million and $410 million and an adjusted EBITDA loss between $30 million and $35 million.